Premium
Bipolar disorder patients using lithium have lower self‐harm rates
Publication year - 2016
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30169
Subject(s) - quetiapine , olanzapine , bipolar disorder , lithium (medication) , suicide rates , medicine , harm , psychiatry , population , schizophrenia (object oriented programming) , psychology , poison control , injury prevention , emergency medicine , environmental health , social psychology
Bipolar disorder patients taking lithium showed reduced self‐harm and unintentional injury rates compared with patients taking valproate, olanzapine, or quetiapine, a population‐based study conducted in the United Kingdom has found. Researchers could not draw definitive conclusions about the drugs' comparative effects on suicide because of a low overall number of suicides in the study population.